Encompass Health Corporation

DB:HSOA Stock Report

Market Cap: €9.1b

Encompass Health Management

Management criteria checks 3/4

Encompass Health's CEO is Mark Tarr, appointed in Dec 2016, has a tenure of 8.08 years. total yearly compensation is $8.84M, comprised of 11.9% salary and 88.1% bonuses, including company stock and options. directly owns 0.55% of the company’s shares, worth €49.86M. The average tenure of the management team and the board of directors is 11.4 years and 5 years respectively.

Key information

Mark Tarr

Chief executive officer

US$8.8m

Total compensation

CEO salary percentage11.9%
CEO tenure8.1yrs
CEO ownership0.5%
Management average tenure11.4yrs
Board average tenure5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mark Tarr's remuneration changed compared to Encompass Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$432m

Jun 30 2024n/an/a

US$409m

Mar 31 2024n/an/a

US$387m

Dec 31 2023US$9mUS$1m

US$362m

Sep 30 2023n/an/a

US$357m

Jun 30 2023n/an/a

US$336m

Mar 31 2023n/an/a

US$280m

Dec 31 2022US$8mUS$1m

US$256m

Sep 30 2022n/an/a

US$232m

Jun 30 2022n/an/a

US$242m

Mar 31 2022n/an/a

US$253m

Dec 31 2021US$8mUS$1m

US$298m

Sep 30 2021n/an/a

US$316m

Jun 30 2021n/an/a

US$318m

Mar 31 2021n/an/a

US$304m

Dec 31 2020US$7mUS$953k

US$193m

Sep 30 2020n/an/a

US$265m

Jun 30 2020n/an/a

US$285m

Mar 31 2020n/an/a

US$342m

Dec 31 2019US$7mUS$1m

US$358m

Sep 30 2019n/an/a

US$317m

Jun 30 2019n/an/a

US$308m

Mar 31 2019n/an/a

US$309m

Dec 31 2018US$6mUS$963k

US$290m

Compensation vs Market: Mark's total compensation ($USD8.84M) is above average for companies of similar size in the German market ($USD3.31M).

Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.


CEO

Mark Tarr (62 yo)

8.1yrs

Tenure

US$8,836,376

Compensation

Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...


Leadership Team

NamePositionTenureCompensationOwnership
Mark Tarr
CEO, President & Director8.1yrsUS$8.84m0.55%
€ 49.9m
Douglas Coltharp
Executive VP & CFO14.7yrsUS$5.75m0.26%
€ 23.6m
Andrew Price
Senior VP & Chief Accounting Officer15.3yrsUS$1.10m0.076%
€ 6.9m
John Darby
Executive VP8.9yrsUS$3.17m0.084%
€ 7.6m
Elissa Charbonneau
Chief Medical Officer9.5yrsUS$1.30m0.018%
€ 1.7m
Rusty Yeager
Chief Information Officer & Senior VP13.5yrsno datano data
Mark Miller
Senior Vice President of Investor Relations & Strategic Planning3.3yrsno datano data
Dawn Rock
Chief Compliance Officer9.5yrsno datano data
Anthony Hernandez
Chief Human Resources Officer5yrsno datano data
Frank Brown
President of Southwest Region13.3yrsno datano data
Jerry Gray
President of West Region13.3yrsno datano data
Peter Mantegazza
President of Northeast Region16.6yrsno datano data

11.4yrs

Average Tenure

60.5yo

Average Age

Experienced Management: HSOA's management team is seasoned and experienced (11.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Tarr
CEO, President & Director8.1yrsUS$8.84m0.55%
€ 49.9m
Joan Herman
Independent Director12yrsUS$289.80k0.00099%
€ 89.8k
Leslye Katz
Independent Director12yrsUS$294.80k0.00099%
€ 89.8k
Nancy Schlichting
Independent Director7.1yrsUS$259.79k0.000040%
€ 3.6k
Gregory Carmichael
Independent Chairman5yrsUS$276.01k0.0038%
€ 344.5k
Patricia Maryland
Independent Director5yrsUS$256.01k0.000020%
€ 1.8k
Christopher Reidy
Independent Director3.3yrsUS$272.98k0.012%
€ 1.1m
Edward Christie
Director1.2yrsUS$74.45k0.00049%
€ 44.4k
Kevin O'Connor
Independent Director2.8yrsUS$252.54k0.0010%
€ 90.7k
Terrance Williams
Independent Director5yrsUS$271.01k0.00035%
€ 31.7k

5.0yrs

Average Tenure

64.5yo

Average Age

Experienced Board: HSOA's board of directors are considered experienced (5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:56
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Encompass Health Corporation is covered by 36 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null RESEARCH DEPARTMENTAvondale Partners
Matthew GillmorBaird
Ishan MajumdarBaptista Research